SCHEMBL7333302

SCHEMBL7333302

CCOC(=O)c1ccc2n1Cc1ccccc1N(C(=O)c1ccc(N)cc1)C2

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 11/20 0.50
AVPR2 P30518 9/20 0.45
LMNA P02545 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
MAOA P21397 1/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7333536 0.88 AVPR1A (0.45) AVPR1AAVPR2NPC1RAB9ASMN1; SMN2
SCHEMBL5788208 0.82 AVPR1A (0.50) AVPR1AAVPR2NPC1RAB9ASMN1; SMN2
SCHEMBL7340153 0.81 AVPR1A (0.43) AVPR1AAVPR2LMNASMN1; SMN2POLB
SCHEMBL7333493 0.80 AVPR1A (0.48) AVPR1AAVPR2
SCHEMBL8628737 0.80 MEN1 (0.45) AVPR1AAVPR2SMN1; SMN2KMT2A
SCHEMBL7333306 0.79 AVPR2 (0.64) AVPR1AAVPR2
SCHEMBL7333047 0.78 AVPR1A (0.54) AVPR1AAVPR2
SCHEMBL8317560 0.78 AVPR2 (0.43) AVPR1AAVPR2LMNANPC1SMN1; SMN2
SCHEMBL7339753 0.75 AVPR2 (0.57) AVPR1AAVPR2
SCHEMBL7339252 0.74 AVPR2 (0.49) AVPR1AAVPR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5968930-A FOR TREATMENT AND/OR PREVENTION OF HYPERTENSION, CARDIAC INSUFFICIENCY, CORONARY VASOSPASM, CARDIAC ISCHEMIA, RENAL VASOSPASM, LIVER CIRRHOSIS, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, BRAIN EDEMA, CEREBRAL ISCHEMIA AMERICAN CYANAMID COMPANY (US) 1999-10-19 US disclosed
US-5968937-A FOR TREATMENT AND/OR PREVENTION OF HYPERTENSION, CARDIAC INSUFFICIENCY, CORONARY VASOSPASM, CARDIAC ISCHEMIA, RENAL VASOSPASM, LIVER CIRRHOSIS, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, BRAIN EDEMA, CEREBRAL ISCHEMIA AMERICAN CYANAMID COMPANY (US) 1999-10-19 US disclosed
EP-0636625-B1 Tricyclic diazepines vasopressin and oxytocin antagonists AMERICAN CYANAMID CO (US) 1999-01-27 EP disclosed
US-5624923-A UROGENITAL AND CARDIOVASCULAR DISORDERS AMERICAN CYANAMID COMPANY (US) 1997-04-29 US disclosed